B.Pharm

Amneal is a global essential medicines company powered by a robust U.S. generics business. Amneal is a growing branded business with deepening portfolios in institutional injectables, biosimilars and select international markets including India.

Post : Officer / Senior Officer / Executive 

After a journey of growth spanning 27 years as Cadila Healthcare Ltd. and the Zydus Group, we have evolved and transformed ourselves in response to the changing times. Our legacy of over 70 years in healthcare and being dedicated to life in all its dimensions is reaffirmed in our new mission, vision and purpose. Unifying ourselves under the Zydus name, Cadila Healthcare Ltd., is renamed as Zydus Lifesciences Ltd.

Inviting candidates for a walk - in interview for Injectable Manufacturing Plant at Vadodara

Nectar Lifesciences Ltd., Chandigarh, India a USD 200 million company engaged in the business of manufacturing & marketing products in lifesciences particularly Antibacterial I.e. Cephalosporins with 40% market share in API's I.e. 3rd & 4th generation Cephalosporins out of India.

Quality Assurance
Post : Chemist/Officer/ Executive
Qualification : B. Pharma/M. Pharma
Experience : 1 -8 years of relevant experience 

Granules India is a vertically integrated, high-growth pharmaceutical company with 38 years of proven performance and increasing performance and increasing presence across the world. Headquartered in Hyderabad, India, Granules offers collaborative and strategic partnership to global pharmaceutical leaders by producing best quality API, PFI and FD through manufacturing excellence, process innovation and regulatory expertise.

Walk in Interview - QA & QC (Formulations - OSD)

Sun Pharmaceutical Industries Limited is taking this opportunity to balance employment and the medications to the world. We are hereby inviting candidates who are interested to join India's No. 1 company in Pharmaceutical sector.

Hiring For Sun Pharma Paonta Sahib

Piramal Group has interests in a portfolio of businesses including financial services (Piramal Enterprises Limited), pharmaceuticals (Piramal Pharma Limited), and real estate (Piramal Realty). With operations in 30 countries and brand presence in over 100 markets, the Group’s turnover is ~1.9 billion usd in FY 2022. Driven by its core values, the Group pursues inclusive growth, while adhering to ethical and value-driven practices. 

Post : Executive Pharmacovigilance

Torrent Pharma, the flagship Company of Torrent Group is one of the leading pharma companies of the Country. The Company was a pioneer in initiating the concept of niche marketing in India and today is ranked amongst the leaders in therapeutic segment of cardiovascular (CV), central nervous system (CNS), gastro-intestinal (GI) and women healthcare (WHC). The Company also has significant presence in diabetology, pain management, gynaecology, oncology and anti-infective segments.

Department : SCM-PPC

For pharma and biopharma companies, building quality into your products from an early stage is a key factor in regulatory approval and market success. Thus, the FDA mentions “Design of Experiments” (DoE) as an essential tool for achieving both regulatory compliance and faster time to market. To help you build quality into your process as outlined by ICH Q8, Q9, and Q10, Eminence Business Media is planning a two-day robust training program on “Advance DoE Workshop 2024” on May 9th – 10th.

Nitrosamine Advanced Workshop 2024
May 9th – 10th, 2024 | Radisson Blu Mumbai International Airport

About the Event :
Presence of Nitrosamines, which are probable human carcinogens, has been an evolving challenge facing the pharmaceutical industry. Regulators became first aware of this impurity in mid – 2018, when NDMA was found in blood pressure medicine known as sartans. Ever since, the pharmaceutical industry has been working hard to mitigate the formation of Nitrosamines Impurities.